Who owns Sage Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Sage Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sage Therapeutics stock

Who bought or sold Sage Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Huntington National Bank 1.00 $9.000000 0% Dec 2025
 View chart

Who sold out of Sage Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
XTX Topco Sep 2025 30k $0
DekaBank Deutsche Girozentrale Dec 2025 22k $460k
Advisor Group Holdings Sep 2025 4.0k $35k